title: Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.
abstract: OBJECTIVE
  To assess the efficacy of a chlorhexidine-impregnated dressing for prevention of central venous catheter-related colonization and catheter-related bloodstream infection using meta-analysis.
  
  
  METHODS
  Multiple computerized database searches supplemented by manual searches including relevant conference proceedings.
  
  
  METHODS
  Randomized controlled trials evaluating the efficacy of a chlorhexidine-impregnated dressing compared with conventional dressings for prevention of catheter colonization and catheter-related bloodstream infection.
  
  
  METHODS
  Data were extracted on patient and catheter characteristics and outcomes.
  
  
  RESULTS
  Nine randomized controlled trials met the inclusion criteria. Use of a chlorhexidine-impregnated dressing resulted in a reduced prevalence of catheter-related bloodstream infection (random effects relative risk, 0.60; 95% CI, 0.41-0.88, p = 0.009). The prevalence of catheter colonization was also markedly reduced in the chlorhexidine-impregnated dressing group (random effects relative risk, 0.52; 95% CI, 0.43-0.64; p < 0.001). There was significant benefit for prevention of catheter colonization and catheter-related bloodstream infection, including arterial catheters used for hemodynamic monitoring. Other than in low birth weight infants, adverse effects were rare and minor.
  
  
  CONCLUSIONS
  Our analysis shows that a chlorhexidine-impregnated dressing is beneficial in preventing catheter colonization and, more importantly, catheter-related bloodstream infection and warrants routine use in patients at high risk of catheter-related bloodstream infection and central venous catheter or arterial catheter colonization.
authors.affiliation: 1William S. Middleton Memorial Veterans Hospital, Madison, WI. 2Section of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI. 3Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN. 4Biostatistical Consulting Unit, Department of Community Health Sciences, University of Manitoba, Winnipeg, MB.
authors.forename: Nasia
authors.initials: N
authors.lastname: Safdar
authors.forename: John C
authors.initials: JC
authors.lastname: O'Horo
authors.forename: Aiman
authors.initials: A
authors.lastname: Ghufran
authors.forename: Allison
authors.initials: A
authors.lastname: Bearden
authors.forename: Maria Eugenia
authors.initials: ME
authors.lastname: Didier
authors.forename: Dan
authors.initials: D
authors.lastname: Chateau
authors.forename: Dennis G
authors.initials: DG
authors.lastname: Maki
mesh_terms: D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000009:adverse effects; D001458:Bandages; D055499:Catheter-Related Infections / Q000517:prevention & control*; D002710:Chlorhexidine / Q000008:administration & dosage* / Q000009:adverse effects; D004866:Equipment Contamination; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D000891:Anti-Infective Agents, Local; D002710:Chlorhexidine